Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics have?
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics has 551 citations in the OpenAlex counts ScholarIQ stores.
When was Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics published?
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics has 2006 year in the ScholarIQ index.
What is the open-access status of Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics?
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics has closed oa status in the ScholarIQ index.
What is the DOI of Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics?
The DOI for Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics is on the source record.
What is the PMID of Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics?
The PMID for Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics is on the source record.
What is the OpenAlex record for Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics?
The OpenAlex for Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics is on the source record.